FirmAtlas

Company handbook · CLX · Prepared by FirmAtlas · firmatlas.app · printed 2026-10-17

CLX · CIK 21076 · LATEST FILING: 10-K FY26 · FILED AUG 7, 2026

THE CLOROX COMPANY

$87.09 +0.89 (+1.03%)

Close, Oct 16, 2026 · 52-week $79–129

Last fiscal year

THE CLOROX COMPANY reported revenue of $7.1B for the year ended Jun 30, 2025 (FY25), up 0.2% from FY24. Net income was $810M, operating cash flow $981M and free cash flow $761M. Source: 10-K filed Aug 8, 2025.

Market cap

$10.7B

P/E

14.1

Div yield

5.71%

Revenue 1Y

0.2%/yr

EPS 1Y

189.8%/yr

Shares 1Y

−1%

Loading chart…

Daily closes, split-adjusted · ratios at each fiscal year end

Company

CEOLinda Rendle

HQOakland, CA

AuditorErnst & Young LLP

Employees9,200

Year endsJune

Revenue by segment · FY25

Health And Wellness38%

Household28%

Lifestyle18%

International15%

Compounded growth & averages

10Y

TTM

Share price

−3.3%

−11.8%

−11.3%

−25.9%

Upgrade to see 10 years

Share price: yearly compound rate of the traded close; the last column is the past year.

Where the cash went · FY24–FY25

$2.0B deployed

Capex $432M 22.0%

Dividends $1.2B 61.0%

Buybacks $332M 16.9%

Operating cash flow over the period: $1.7B. Total debt changed by +$3M. R&D of $247M is already inside operating costs.

Sources 10-K FY26 10-Q Mar '26 All filings on EDGAR

Latest filings

Aug 3, 2026 Quarterly results 8-K Jun 17, 2026 Executive or director change 8-K May 28, 2026 Executive or director change 8-K May 11, 2026 Other announcement 8-K Apr 30, 2026 Quarterly results 8-K

Growth engines

How much of the profit growth came from new investment, and how much from running the business better.

Upgrade to see 10 years

Financials

Last 2 years · Upgrade to see 10 years · USD millions · each year opens its 10-K · FY25 = year ended Jun 30, 2025 · change vs previous year

Last 4 quarters · USD millions · quarter-end month shown · change vs same quarter a year earlier

TTM = the last four quarters, to Mar '26. Balance-sheet rows show that latest quarter. “—” where the quarters do not add up to the annual figures. No TTM for cash: our quarterly rows do not hold short-term investments yet, and annual cash includes them.

Income

FY24 FY25

TTM

Revenue

7,093

7,104+0.2%

6,760

YoY

+0.2%

Gross profit

3,048

3,213+5.4%

2,964

Gross margin

43.0%

45.2%+2.3 pp

—

Interest expense

88−2.2%

—

Net income

280

810+189.3%

756

YoY

+189.3%

Net margin

3.9%

11.4%+7.5 pp

—

EPS (diluted, $)

2.25

6.52+189.8%

6.19

YoY

+189.8%

Balance sheet

FY24 FY25

TTM

Total assets

5,751

5,561−3.3%

6,436

Cash & short-term investments

207

170−17.9%

—

Accounts receivable

695

821+18.1%

—

Inventory

637

523−17.9%

—

Net PP&E

1,315

1,267−3.7%

—

Other assets

2,897

2,780−4.0%

—

Total liabilities

5,423

5,240−3.4%

6,503

Accounts payable

950

838−11.8%

—

Total debt

2,485

2,488+0.1%

4,078

Other liabilities

1,988

1,914−3.7%

—

Shareholders’ equity

328

321−2.1%

(67)

Total liabilities = total assets − shareholders’ equity, so it includes minority interest where a company has one.

Cash flow statement · as filed

FY24 FY25

TTM

Cash from operations

695

981+41.2%

576

Net income

292

824+182.2%

—

Depreciation & amortization

235

219−6.8%

—

Stock-based compensation

81+9.5%

—

Working capital & other

(143)−252.1%

—

Cash from investing

(175)

(94)n/m

—

Capex

(212)

(220)n/m

—

Other investing

126+240.5%

—

Cash from financing

(655)

(924)n/m

—

Debt raised

—

Debt repaid

—

Dividends

(595)

(602)n/m

—

Buybacks

(332)n/m

—

Shares issued

61+165.2%

—

Other financing

(83)

(51)n/m

—

Net change in cash

(161)

(37)n/m

—

Free cash flow (OCF − capex)

483

761+57.6%

380

Where the cash went

FY24 FY25

TTM

Operating cash flow

695

981+41.2%

576

Reinvested in the business

212

220+3.8%

—

% of operating cash flow

30.5%

22.4%

Capex

212

220+3.8%

196

R&D (memo, already in costs)

126

121−4.0%

—

Free cash flow

483

761+57.6%

380

YoY

+57.6%

Returned to shareholders

595

934+57.0%

—

% of free cash flow

123.2%

122.7%

Dividends

595

602+1.2%

—

Buybacks

332n/m

—

Change in total debt

—

Cash left over

—

(170)

—

FCF conversion (FCF ÷ net income)

172.5%

94.0%−78.5 pp

—

Owner earnings

—

685

—

Owner earnings margin

—

9.6%

—

Buyback yield

—

2.3%

—

Returns & ratios

FY24 FY25

TTM

Debt / equity

7.58x

7.75x+0.17x

—

Cash conversion cycle (days)

13+5 d

—

ROE

85.4%

252.3%+167.0 pp

—

ROA

4.9%

14.6%+9.7 pp

—

Invested capital (operating)

1,697

1,773+4.5%

—

Invested capital (all)

2,606

2,639+1.3%

—

Debtor days

42+6 d

—

Inventory days

49−8 d

—

Days payable

79−7 d

—

Income

Jun '25

Sep '25

Dec '25

Mar '26

Revenue

1,988

1,429

1,673

1,670

vs year-ago quarter

Gross profit

924

596

722

Gross margin

46.5%

41.7%

43.2%

Net income

332

157

187

vs year-ago quarter

Net margin

16.7%

5.6%

9.4%

11.2%

EPS (diluted, $)

2.71

0.65

1.29

1.54

vs year-ago quarter

Balance sheet

Jun '25

Sep '25

Dec '25

Mar '26

Total assets

5,561

5,528

5,613

6,436

Cash & equivalents

170

169

229

1,187

Total debt

2,488

2,703

2,793

4,078

Shareholders’ equity

321

(22)

(125)

(67)

Cash flow

Jun '25

Sep '25

Dec '25

Mar '26

Operating cash flow

294

311

(122)

Capex

Free cash flow

219

269

(165)

vs year-ago quarter